4.0
Jun 29, 2017
Moderna is doing well during a difficult hypergrowth phase
Current employee, more than 1 year
Recommend
CEO approval
Business Outlook
Pros
Amazing talent in science, engineering, and bioinformatics Committment to innovation in "digital" infrastructure and custom automation Broad and deep pipeline, with vaccines leading the way Enough financial resources to solve the challenging scientific and engineering problems Engaged and very smart executive team
Cons
growing fast, but the amount of work is huge, and everyone is working really hard senior management is learning as they go when it comes to clinical development